VivoSim Labs, Inc. VIVS
Set alert
0.15 USD 0.00 -0.84%
At close
0.14 -0.01 -8.68%
Pre-market · Nov 3, 4:00 AM ET
0.1499 Day range 0.1595
0.14 52-week range 3.40
- YTD
- -91.53%
- 1 year
- -94.32%
- Open
- 0.1549
- Prev close
- 0.1546
- Mkt cap
- 2.54M
- Vol
- 532.57K
- Avg vol
- 2.69M
- EPS
- -4.47
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 0.1499
- High
- 0.1595
News
-
1 week ago benzinga.com
VivoSim Labs To Extend Its Human Tissue Platform Beyond Toxicology With Efficacy Testing Services Built On NAMkind Disease Models Of The Liver And Intestine
The disease models are built with cells from patient donors, so they carry features of the disease itself. Drug developers can measure whether a candidate acts on those disease features in human…
3 weeks ago benzinga.com
12 Health Care Stocks Moving In Monday's After-Market Session
Gainers Biomea Fusion (NASDAQ:BMEA) stock increased by 11.0% to $1.51 during Monday's after-market session. The market value of their outstanding shares is at $102.9 million. iTonic Holdings…
-
3 weeks ago benzinga.com
Vivosim Labs Notes FDA's Direct Final Rule Clarifying That Non-Animal Methods Can Be Used Where Appropriate For Testing Safety Of Drugs And Biological Products For Human Use
The FDA’s new rule replaces the term "animal tests" with "nonclinical tests" across its regulatory framework, formally opening pathways for NAMs, including human cell-based tests such as those…